Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

118.28
BATS BZX Real-Time Price
As of 1:57pm ET
 +0.75 / +0.64%
Today’s Change
55.00
Today|||52-Week Range
122.34
+17.96%
Year-to-Date
Wall Street Associates Buys PGT Innovations Inc, Carbonite Inc, Obalon Therapeutics I...
Jan 18 / GuruFocus News - Paid Partner Content
Incyte's Prospects Get Even Brighter With Merck Announcement
Jan 10 / MotleyFool.com - Paid Partner Content
4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal
Jan 10 / Zacks.com - Paid Partner Content
3 Stocks Expected to More Than Double Their Earnings in 2017
Jan 08 / MotleyFool.com - Paid Partner Content
Incyte/Merck to Start More Epacadostat-Keytruda Studies
Jan 10 / Zacks.com - Paid Partner Content
Biotech Investing: 3 Bold Predictions for 2017
Jan 06 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close117.53
Today’s open118.18
Day’s range117.66 - 122.34
Volume99,831
Average volume (3 months)1,415,688
Market cap$22.1B
Dividend yield--
Data as of 1:57pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+2,001.67%
Earnings growth (next 5 years)+94.65%
Revenue growth (last year)+47.36%
P/E ratio150.2
Price/Sales26.95
Price/Book128.17

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.42+0.52%
MYLMylan NV+0.10+0.27%
BAXBaxter International...-0.23-0.49%
ZTSZoetis Inc+0.71+1.33%
Data as of 1:58pm ET, 01/20/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts


Search for Jobs